_id
6914866cccc777a4e85d964f
Ticker
OBIO
Name
Orchestra BioMed Holdings Inc.
Exchange
NASDAQ
Address
150 Union Square Drive, New Hope, PA, United States, 18938
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://orchestrabiomed.com
Description
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.
Last Close
4.17
Volume
169826
Current Price
4.8
Change
0.16
Last Updated
2026-01-05T11:59:00.944Z
Image
data:image/webp;base64,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
Ipo Date
2020-08-04T00:00:00.000Z
Market Cap
243362992
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.993
Sentiment Sources
3
Rating
4.5714
Target Price
13.5714
Strong Buy
4
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
861000
Cost Of Revenue
49000
Gross Profit
812000
Operating Expenses
21125000
Operating Income
-20313000
Interest Expense
515000
Pretax Income
-20828000
Net Income
-20828000
Eps
-0.5424987385628045
Dividends Per Share
-
Shares Outstanding
56464731
Income Tax Expense
-
EBITDA
-20232000
Operating Margin
-2359.2334494773518
Total Other Income Expense Net
-515000
Cash
42012000
Short Term Investments
53808000
Receivables
52000
Inventories
365000
Total Current Assets
97768000
Property Plant Equipment
3248000
Total Assets
104807000
Payables
8473000
Short Term Debt
696000
Long Term Debt
14204000
Total Liabilities
61068000
Equity
43739000
Bs_currency_symbol
USD
Depreciation
81000
Change In Working Capital
2541000
Cash From Operations
-14550000
Capital Expenditures
310000
Cash From Investing
-38584000
Cash From Financing
76397000
Net Change In Cash
23263000
Cf_currency_symbol
USD
PE
-
PB
4.213288753743798
ROE
-47.618829877226275
ROA
-19.87271842529602
FCF
-14860000
Fcf Percent
-17.259001161440185
Piotroski FScore
1
Health Score
20
Deep Value Investing Score
2
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
3
Net Net Investing Score
1
Quality Investing Score
1.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
861000
Quarters > 0 > income Statement > cost Of Revenue
49000
Quarters > 0 > income Statement > gross Profit
812000
Quarters > 0 > income Statement > operating Expenses
21125000
Quarters > 0 > income Statement > operating Income
-20313000
Quarters > 0 > income Statement > interest Expense
515000
Quarters > 0 > income Statement > pretax Income
-20828000
Quarters > 0 > income Statement > net Income
-20828000
Quarters > 0 > income Statement > eps
-0.5424987385628045
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
38392716
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-20232000
Quarters > 0 > income Statement > operating Margin
-2359.2334494773518
Quarters > 0 > income Statement > total Other Income Expense Net
-515000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
42012000
Quarters > 0 > balance Sheet > short Term Investments
53808000
Quarters > 0 > balance Sheet > receivables
52000
Quarters > 0 > balance Sheet > inventories
365000
Quarters > 0 > balance Sheet > total Current Assets
97768000
Quarters > 0 > balance Sheet > property Plant Equipment
3248000
Quarters > 0 > balance Sheet > total Assets
104807000
Quarters > 0 > balance Sheet > payables
8473000
Quarters > 0 > balance Sheet > short Term Debt
696000
Quarters > 0 > balance Sheet > long Term Debt
14204000
Quarters > 0 > balance Sheet > total Liabilities
61068000
Quarters > 0 > balance Sheet > equity
43739000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-20828000
Quarters > 0 > cash Flow > depreciation
81000
Quarters > 0 > cash Flow > change In Working Capital
2541000
Quarters > 0 > cash Flow > cash From Operations
-14550000
Quarters > 0 > cash Flow > capital Expenditures
310000
Quarters > 0 > cash Flow > cash From Investing
-38584000
Quarters > 0 > cash Flow > cash From Financing
76397000
Quarters > 0 > cash Flow > net Change In Cash
23263000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.5424987385628045
Quarters > 0 > ratios > PB
4.213288753743798
Quarters > 0 > ratios > ROE
-47.618829877226275
Quarters > 0 > ratios > ROA
-19.87271842529602
Quarters > 0 > ratios > FCF
-14860000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-17.259001161440185
Quarters > 0 > health Score
20
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
836000
Quarters > 1 > income Statement > cost Of Revenue
46000
Quarters > 1 > income Statement > gross Profit
790000
Quarters > 1 > income Statement > operating Expenses
20117000
Quarters > 1 > income Statement > operating Income
-19327000
Quarters > 1 > income Statement > interest Expense
36000
Quarters > 1 > income Statement > pretax Income
-19363000
Quarters > 1 > income Statement > net Income
-19363000
Quarters > 1 > income Statement > eps
-0.5043404587474353
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
38392716
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-19246000
Quarters > 1 > income Statement > operating Margin
-2311.842105263158
Quarters > 1 > income Statement > total Other Income Expense Net
-36000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
18749000
Quarters > 1 > balance Sheet > short Term Investments
15175000
Quarters > 1 > balance Sheet > receivables
83000
Quarters > 1 > balance Sheet > inventories
185000
Quarters > 1 > balance Sheet > total Current Assets
35882000
Quarters > 1 > balance Sheet > property Plant Equipment
3172000
Quarters > 1 > balance Sheet > total Assets
42825000
Quarters > 1 > balance Sheet > payables
5308000
Quarters > 1 > balance Sheet > short Term Debt
642000
Quarters > 1 > balance Sheet > long Term Debt
14384000
Quarters > 1 > balance Sheet > total Liabilities
42530000
Quarters > 1 > balance Sheet > equity
295000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-19363000
Quarters > 1 > cash Flow > depreciation
81000
Quarters > 1 > cash Flow > change In Working Capital
358000
Quarters > 1 > cash Flow > cash From Operations
-15527000
Quarters > 1 > cash Flow > capital Expenditures
34000
Quarters > 1 > cash Flow > cash From Investing
16356000
Quarters > 1 > cash Flow > cash From Financing
-428000
Quarters > 1 > cash Flow > net Change In Cash
401000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.5043404587474353
Quarters > 1 > ratios > PB
624.6950400000001
Quarters > 1 > ratios > ROE
-6563.728813559323
Quarters > 1 > ratios > ROA
-45.214244016345596
Quarters > 1 > ratios > FCF
-15561000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-18.613636363636363
Quarters > 1 > health Score
9
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
868000
Quarters > 2 > income Statement > cost Of Revenue
44000
Quarters > 2 > income Statement > gross Profit
824000
Quarters > 2 > income Statement > operating Expenses
19745000
Quarters > 2 > income Statement > operating Income
-18921000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-18755000
Quarters > 2 > income Statement > net Income
-18755000
Quarters > 2 > income Statement > eps
-0.4905139108097418
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
38235409
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-18672000
Quarters > 2 > income Statement > operating Margin
-2179.838709677419
Quarters > 2 > income Statement > total Other Income Expense Net
166000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
18348000
Quarters > 2 > balance Sheet > short Term Investments
31536000
Quarters > 2 > balance Sheet > receivables
89000
Quarters > 2 > balance Sheet > inventories
135000
Quarters > 2 > balance Sheet > total Current Assets
51903000
Quarters > 2 > balance Sheet > property Plant Equipment
3369000
Quarters > 2 > balance Sheet > total Assets
59051000
Quarters > 2 > balance Sheet > payables
5563000
Quarters > 2 > balance Sheet > short Term Debt
590000
Quarters > 2 > balance Sheet > long Term Debt
14338000
Quarters > 2 > balance Sheet > total Liabilities
42194000
Quarters > 2 > balance Sheet > equity
16857000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-18755000
Quarters > 2 > cash Flow > depreciation
83000
Quarters > 2 > cash Flow > change In Working Capital
-990000
Quarters > 2 > cash Flow > cash From Operations
-16616000
Quarters > 2 > cash Flow > capital Expenditures
112000
Quarters > 2 > cash Flow > cash From Investing
12999000
Quarters > 2 > cash Flow > cash From Financing
-296000
Quarters > 2 > cash Flow > net Change In Cash
-3913000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.4905139108097418
Quarters > 2 > ratios > PB
10.88746296494038
Quarters > 2 > ratios > ROE
-111.25941745269029
Quarters > 2 > ratios > ROA
-31.760681444852757
Quarters > 2 > ratios > FCF
-16728000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-19.27188940092166
Quarters > 2 > health Score
13
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
253000
Quarters > 3 > income Statement > cost Of Revenue
58000
Quarters > 3 > income Statement > gross Profit
195000
Quarters > 3 > income Statement > operating Expenses
16872000
Quarters > 3 > income Statement > operating Income
-16677000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-16155000
Quarters > 3 > income Statement > net Income
-16155000
Quarters > 3 > income Statement > eps
-0.42441383930118387
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
38064263
Quarters > 3 > income Statement > income Tax Expense
-30724
Quarters > 3 > income Statement > EBITDA
-16593000
Quarters > 3 > income Statement > operating Margin
-6591.699604743083
Quarters > 3 > income Statement > total Other Income Expense Net
522000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
22261000
Quarters > 3 > balance Sheet > short Term Investments
44551000
Quarters > 3 > balance Sheet > receivables
92000
Quarters > 3 > balance Sheet > inventories
173000
Quarters > 3 > balance Sheet > total Current Assets
69171000
Quarters > 3 > balance Sheet > property Plant Equipment
3487000
Quarters > 3 > balance Sheet > total Assets
76173000
Quarters > 3 > balance Sheet > payables
5134000
Quarters > 3 > balance Sheet > short Term Debt
550000
Quarters > 3 > balance Sheet > long Term Debt
14292000
Quarters > 3 > balance Sheet > total Liabilities
43215000
Quarters > 3 > balance Sheet > equity
32958000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-16155000
Quarters > 3 > cash Flow > depreciation
84000
Quarters > 3 > cash Flow > change In Working Capital
-1363000
Quarters > 3 > cash Flow > cash From Operations
-13538000
Quarters > 3 > cash Flow > capital Expenditures
106000
Quarters > 3 > cash Flow > cash From Investing
-3753000
Quarters > 3 > cash Flow > cash From Financing
13947000
Quarters > 3 > cash Flow > net Change In Cash
-3344000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.42441383930118387
Quarters > 3 > ratios > PB
5.543675659930821
Quarters > 3 > ratios > ROE
-49.016930638995085
Quarters > 3 > ratios > ROA
-21.208302154306644
Quarters > 3 > ratios > FCF
-13644000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-53.92885375494071
Quarters > 3 > health Score
20
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2638000
Annuals > 0 > income Statement > cost Of Revenue
204000
Annuals > 0 > income Statement > gross Profit
2434000
Annuals > 0 > income Statement > operating Expenses
66735000
Annuals > 0 > income Statement > operating Income
-64301000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-61024000
Annuals > 0 > income Statement > net Income
-61024000
Annuals > 0 > income Statement > eps
-1.6573132286696286
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
36821042
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-63993000
Annuals > 0 > income Statement > operating Margin
-2437.4905231235784
Annuals > 0 > income Statement > total Other Income Expense Net
3277000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
22261000
Annuals > 0 > balance Sheet > short Term Investments
44551000
Annuals > 0 > balance Sheet > receivables
92000
Annuals > 0 > balance Sheet > inventories
173000
Annuals > 0 > balance Sheet > total Current Assets
69171000
Annuals > 0 > balance Sheet > property Plant Equipment
3487000
Annuals > 0 > balance Sheet > total Assets
76173000
Annuals > 0 > balance Sheet > payables
5134000
Annuals > 0 > balance Sheet > short Term Debt
550000
Annuals > 0 > balance Sheet > long Term Debt
14292000
Annuals > 0 > balance Sheet > total Liabilities
43215000
Annuals > 0 > balance Sheet > equity
32958000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-61024000
Annuals > 0 > cash Flow > depreciation
308000
Annuals > 0 > cash Flow > change In Working Capital
-765000
Annuals > 0 > cash Flow > cash From Operations
-50558000
Annuals > 0 > cash Flow > capital Expenditures
289000
Annuals > 0 > cash Flow > cash From Investing
13089000
Annuals > 0 > cash Flow > cash From Financing
29171000
Annuals > 0 > cash Flow > net Change In Cash
-8298000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.6573132286696286
Annuals > 0 > ratios > PB
4.815179653498391
Annuals > 0 > ratios > ROE
-185.15686631470356
Annuals > 0 > ratios > ROA
-80.11237577619367
Annuals > 0 > ratios > FCF
-50847000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-19.274829416224414
Annuals > 0 > health Score
19
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2760000
Annuals > 1 > income Statement > cost Of Revenue
186000
Annuals > 1 > income Statement > gross Profit
2574000
Annuals > 1 > income Statement > operating Expenses
54080000
Annuals > 1 > income Statement > operating Income
-51506000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-49120000
Annuals > 1 > income Statement > net Income
-49120000
Annuals > 1 > income Statement > eps
-1.478394759451749
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
33225226
Annuals > 1 > income Statement > income Tax Expense
119105
Annuals > 1 > income Statement > EBITDA
-51219000
Annuals > 1 > income Statement > operating Margin
-1866.1594202898552
Annuals > 1 > income Statement > total Other Income Expense Net
2386000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
30559000
Annuals > 1 > balance Sheet > short Term Investments
57036000
Annuals > 1 > balance Sheet > receivables
99000
Annuals > 1 > balance Sheet > inventories
146000
Annuals > 1 > balance Sheet > total Current Assets
89114000
Annuals > 1 > balance Sheet > property Plant Equipment
2834000
Annuals > 1 > balance Sheet > total Assets
95212000
Annuals > 1 > balance Sheet > payables
2900000
Annuals > 1 > balance Sheet > short Term Debt
649000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
27169000
Annuals > 1 > balance Sheet > equity
68043000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-49120000
Annuals > 1 > cash Flow > depreciation
287000
Annuals > 1 > cash Flow > change In Working Capital
-3307000
Annuals > 1 > cash Flow > cash From Operations
-46127000
Annuals > 1 > cash Flow > capital Expenditures
78000
Annuals > 1 > cash Flow > cash From Investing
10687000
Annuals > 1 > cash Flow > cash From Financing
46215000
Annuals > 1 > cash Flow > net Change In Cash
10775000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.478394759451749
Annuals > 1 > ratios > PB
2.104562174801228
Annuals > 1 > ratios > ROE
-72.18964478344576
Annuals > 1 > ratios > ROA
-51.590135697181026
Annuals > 1 > ratios > FCF
-46205000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-16.740942028985508
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
3533000
Annuals > 2 > income Statement > cost Of Revenue
322000
Annuals > 2 > income Statement > gross Profit
3211000
Annuals > 2 > income Statement > operating Expenses
35868000
Annuals > 2 > income Statement > operating Income
-32657000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-33608000
Annuals > 2 > income Statement > net Income
-33608000
Annuals > 2 > income Statement > eps
-1.3193867050276022
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
25472441
Annuals > 2 > income Statement > income Tax Expense
-222000
Annuals > 2 > income Statement > EBITDA
-32435000
Annuals > 2 > income Statement > operating Margin
-924.3419190489669
Annuals > 2 > income Statement > total Other Income Expense Net
-951000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
19784000
Annuals > 2 > balance Sheet > short Term Investments
64001000
Annuals > 2 > balance Sheet > receivables
96000
Annuals > 2 > balance Sheet > inventories
276000
Annuals > 2 > balance Sheet > total Current Assets
84690000
Annuals > 2 > balance Sheet > property Plant Equipment
3676000
Annuals > 2 > balance Sheet > total Assets
95572000
Annuals > 2 > balance Sheet > payables
3968000
Annuals > 2 > balance Sheet > short Term Debt
697000
Annuals > 2 > balance Sheet > long Term Debt
9490000
Annuals > 2 > balance Sheet > total Liabilities
43038000
Annuals > 2 > balance Sheet > equity
52534000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-33608000
Annuals > 2 > cash Flow > depreciation
222000
Annuals > 2 > cash Flow > change In Working Capital
-451000
Annuals > 2 > cash Flow > cash From Operations
-29289000
Annuals > 2 > cash Flow > capital Expenditures
591000
Annuals > 2 > cash Flow > cash From Investing
-64122000
Annuals > 2 > cash Flow > cash From Financing
103257000
Annuals > 2 > cash Flow > net Change In Cash
9846000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.3193867050276022
Annuals > 2 > ratios > PB
2.0898127062473826
Annuals > 2 > ratios > ROE
-63.97380743899189
Annuals > 2 > ratios > ROA
-35.16511112041184
Annuals > 2 > ratios > FCF
-29880000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-8.457401641664308
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-782000
Annuals > 3 > income Statement > cost Of Revenue
199000
Annuals > 3 > income Statement > gross Profit
-981000
Annuals > 3 > income Statement > operating Expenses
20818000
Annuals > 3 > income Statement > operating Income
-21799000
Annuals > 3 > income Statement > interest Expense
927000
Annuals > 3 > income Statement > pretax Income
-23014000
Annuals > 3 > income Statement > net Income
-23014000
Annuals > 3 > income Statement > eps
-1.1253789731051345
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
20450000
Annuals > 3 > income Statement > income Tax Expense
927000
Annuals > 3 > income Statement > EBITDA
-21618000
Annuals > 3 > income Statement > operating Margin
2787.595907928389
Annuals > 3 > income Statement > total Other Income Expense Net
-1215000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
9938000
Annuals > 3 > balance Sheet > short Term Investments
958000
Annuals > 3 > balance Sheet > receivables
121000
Annuals > 3 > balance Sheet > inventories
68000
Annuals > 3 > balance Sheet > total Current Assets
11319000
Annuals > 3 > balance Sheet > property Plant Equipment
1120000
Annuals > 3 > balance Sheet > total Assets
13527000
Annuals > 3 > balance Sheet > payables
2029000
Annuals > 3 > balance Sheet > short Term Debt
2000000
Annuals > 3 > balance Sheet > long Term Debt
3673000
Annuals > 3 > balance Sheet > total Liabilities
84759000
Annuals > 3 > balance Sheet > equity
-71232000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-23014000
Annuals > 3 > cash Flow > depreciation
181000
Annuals > 3 > cash Flow > change In Working Capital
2597000
Annuals > 3 > cash Flow > cash From Operations
-19429000
Annuals > 3 > cash Flow > capital Expenditures
274000
Annuals > 3 > cash Flow > cash From Investing
13017000
Annuals > 3 > cash Flow > cash From Financing
-3993000
Annuals > 3 > cash Flow > net Change In Cash
-10405000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.1253789731051345
Annuals > 3 > ratios > PB
-1.237358209793351
Annuals > 3 > ratios > ROE
32.30851302785265
Annuals > 3 > ratios > ROA
-170.13380646115178
Annuals > 3 > ratios > FCF
-19703000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
25.195652173913043
Annuals > 3 > health Score
48
Valuation > metrics > PE
-0.5424987385628045
Valuation > metrics > PB
4.213288753743798
Valuation > final Score
37.86711246256202
Valuation > verdict
40.4% Overvalued
Profitability > metrics > ROE
-47.618829877226275
Profitability > metrics > ROA
-21.303493985762213
Profitability > metrics > Net Margin
-24.19047619047619
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.3961910423192117
Risk > metrics > Interest Coverage
-39.442718446601944
Risk > final Score
-128
Risk > verdict
High
Liquidity > metrics > Current Ratio
10.662885810884502
Liquidity > metrics > Quick Ratio
10.623077762024211
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
24.563243400691796
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-2141
Prev Risks > 1
-894
Prev Risks > 2
-122
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:19:55.971Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-10
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.4
Earnings History > 0 > eps Estimate
-0.46
Earnings History > 0 > eps Difference
0.06
Earnings History > 0 > surprise Percent
13.0435
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.5
Earnings History > 1 > eps Estimate
-0.46
Earnings History > 1 > eps Difference
-0.04
Earnings History > 1 > surprise Percent
-8.6957
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.49
Earnings History > 2 > eps Estimate
-0.46
Earnings History > 2 > eps Difference
-0.03
Earnings History > 2 > surprise Percent
-6.5217
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.42
Earnings History > 3 > eps Estimate
-0.45
Earnings History > 3 > eps Difference
0.03
Earnings History > 3 > surprise Percent
6.6667
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-13
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.41
Earnings History > 4 > eps Estimate
-0.4425
Earnings History > 4 > eps Difference
0.0325
Earnings History > 4 > surprise Percent
7.3446
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.45
Earnings History > 5 > eps Estimate
-0.4
Earnings History > 5 > eps Difference
-0.05
Earnings History > 5 > surprise Percent
-12.5
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-13
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.38
Earnings History > 6 > eps Estimate
-0.4
Earnings History > 6 > eps Difference
0.02
Earnings History > 6 > surprise Percent
5
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-27
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.37
Earnings History > 7 > eps Estimate
-0.38
Earnings History > 7 > eps Difference
0.01
Earnings History > 7 > surprise Percent
2.6316
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.38
Earnings History > 8 > eps Estimate
-0.39
Earnings History > 8 > eps Difference
0.01
Earnings History > 8 > surprise Percent
2.5641
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.35
Earnings History > 9 > eps Estimate
-0.41
Earnings History > 9 > eps Difference
0.06
Earnings History > 9 > surprise Percent
14.6341
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-12
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.4
Earnings History > 10 > eps Estimate
-0.28
Earnings History > 10 > eps Difference
-0.12
Earnings History > 10 > surprise Percent
-42.8571
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-01-25
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.08
Earnings History > 11 > eps Estimate
-1.71
Earnings History > 11 > eps Difference
1.63
Earnings History > 11 > surprise Percent
95.3216
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-12-16
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.05
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.05
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-15
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.04
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.04
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-13
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.02
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0043
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0043
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-12
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0044
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0044
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-16
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0045
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.0045
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-17
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.01
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.01
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-10
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.01
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.01
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-05
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0032
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0032
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-07-17
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
0
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ASentiment Recap: Is AMSF stock undervalued right now - Earnings Growth Report & Weekly Breakout Opportunity Watchlist baoquankhu1.vn
Read more →Panic Selling: Can ATOM stock outperform in a bear market - Portfolio Value Report & Real-Time Buy Signal Alerts baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$13.5714
Analyst Picks
Strong Buy
4
Buy
3
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Orchestra BioMed Holdings Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.4
EPS Estimate
-0.46
EPS Difference
0.06
Surprise Percent
13.0435%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.